Practical Guide to Prescribing Sodium-Glucose Cotransporter 2 Inhibitors for Cardiologists

JACC: Heart Failure

Volumn 7, Issue 2, 2019, Pages 169-172

  Vardeny, Orly ^a   Vaduganathan, Muthiah ^b  

^a VA MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

comorbidities; diabetes mellitus; heart failure; prevention

Indexed keywords

CANAGLIFLOZIN; DAPAGLIFLOZIN; EMPAGLIFLOZIN; GLUCOSE; METFORMIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

ACUTE PANCREATITIS; BALANITIS; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DIABETIC KETOACIDOSIS; DRUG COST; DRUG LABELING; ESTIMATED GLOMERULAR FILTRATION RATE; FOOD AND DRUG ADMINISTRATION; FOURNIER GANGRENE; FRACTURE; GENITAL TRACT INFECTION; GLYCEMIC CONTROL; HEALTH INSURANCE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPOGLYCEMIA; HYPOVOLEMIA; KIDNEY INJURY; LEG AMPUTATION; MEDICAL DECISION MAKING; MULTIDISCIPLINARY TEAM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT MONITORING; POLYURIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; UNITED STATES; URINARY TRACT INFECTION; VAGINITIS; COMORBIDITY; GLOBAL HEALTH; PHARMACOLOGY;

CARDIOLOGISTS; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DRUG PRESCRIPTIONS; GLOBAL HEALTH; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS;

EID: 85060237957     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2018.11.013     Document Type: Review

References (5)

1. Zelniker, T.A., Wiviott, S.D., Raz, I., et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet, 2018 Nov 9 [E-pub ahead of print].
2. Arnold, S.V., Inzucchi, S.E., Tang, F., et al. Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: an NCDR research to practice project. Eur J Prev Cardiol 24 (2017), 1637–1645.
3. Vaduganathan, M., Sathiyakumar, V., Singh, A., et al. Prescriber patterns of SGLT2i after expansions of U.S. Food and Drug Administration labeling. J Am Coll Cardiol 72 (2018), 3370–3372.
4. Davies, M.J., D'Alessio, D.A., Fradkin, J., et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41 (2018), 2669–2701.
5. American Diabetes Association. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018. Diabetes Care 41 (2018), S73–S85.